Wondering whatever happened to the possible minimal trial of 30 people in India to get a quick equivalent EUA approval while we do a larger confirmation trial of 500-800 patients as Leronlimab is in use? This is what another MAB has done and it was thought we could do something similar. All though that MAB was rescinded on its approval. It opened a door for quick action and possible quick approval.

Could this be happening and we just have not heard anything about it? Seems to me this would be a prime question for another web call. I am having some withdrawals on information releases and would like to have one of our weekly or bi-weekly calls.

Some say they shouldn’t have updating calls without big news. I am of the opinion that just updating us on our continued direction of all our indications is enough to have an update meeting even bi-weekly. There are many of us that like the updating calls and we hear every time that negative view. Please give that a rest... we know your position.

There... I just had to cover both sides of that issue so we didn’t have to bring it up yet again.